Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocaperidone versus Olanzapine in Schizophrenic Patients (Weight and Symptom Outcomes)
2004-001041-15Phase 2Completed
- Sponsor
- Neuro3d
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ocaperidone in schizophrenia, sponsored by Neuro3d. Started Aug 2004; status: completed.
02
Drugs
ocaperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-001041-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001041-15.